Published 11 November 2002. doi:10.1083/jcb.200207138
© The Rockefeller University Press,
0021-9525/2002/11/453 $5.00
The Journal of Cell Biology, Volume 159, Number 3, 453-463
EGF controls the in vivo developmental potential of a mammary epithelial cell line possessing progenitor properties
Marie-Ange Deugnier1,
Marisa M. Faraldo1,
Bassam Janji1,
Patricia Rousselle2,
Jean Paul Thiery1 and
Marina A. Glukhova1
1 CNRS-Institut Curie, Section de Recherche, 75248 Paris, Cedex 05, France
2 Institut de Biologie et Chimie des Protéines, 69367 Lyon, Cedex 07, France
Address correspondence to Dr. M.A. Glukhova, UMR 144, CNRS-Institut Curie, Section de Recherche, 26 rue d'Ulm, 75248 Paris, Cedex 05, France. Tel.: 33-1-42-34-63-33. Fax: 33-1-42-34-63-49. E-mail: glukhova{at}curie.fr
The bilayered mammary epithelium comprises a luminal layer of secretory cells and a basal layer of myoepithelial cells. Numerous data suggest the existence of self-renewing, pluripotent mammary stem cells; however, their molecular characteristics and differentiation pathways are largely unknown. BC44 mammary epithelial cells in culture, display phenotypic characteristics of basal epithelium, i.e., express basal cytokeratins 5 and 14 and P-cadherin, but no smooth muscle markers. In vivo, after injection into the cleared mammary fat pad, these cells gave rise to bilayered, hollow, alveolus-like structures comprising basal cells expressing cytokeratin 5 and luminal cells positive for cytokeratin 8 and secreting ß-casein in a polarized manner into the lumen. The persistent stimulation of EGF receptor signaling pathway in BC44 cells in culture resulted in the loss of the in vivo morphogenetic potential and led to the induction of active MMP2, thereby triggering cell scattering and motility on laminin 5. These data (a) suggest that BC44 cells are capable of asymmetric division for self-renewal and the generation of a differentiated progeny restricted to the luminal lineage; (b) clarify the function of EGF in the control of the BC44 cell phenotypic plasticity; and (c) suggest a role for this phenomenon in the mammary gland development.
Key Words: mammary epithelium; morphogenesis; differentiation; matrix metalloproteinases; laminin 5

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Korsching, E, Jeffrey, S S, Meinerz, W, Decker, T, Boecker, W, Buerger, H
(2008). Basal carcinoma of the breast revisited: an old entity with new interpretations. J. Clin. Pathol.
61: 553-560
[Abstract]
[Full Text]
-
Vitolo, D., Ciocci, L., Deriu, G., Spinelli, S., Cortese, S., Masuelli, L., Morrone, S., Filice, M. J., Coloni, G. F., Natali, P. G., Baroni, C. D.
(2006). Laminin {alpha}2 Chain-Positive Vessels and Epidermal Growth Factor in Lung Neuroendocrine Carcinoma: A Model of a Novel Cooperative Role of Laminin-2 and Epidermal Growth Factor in Vessel Neoplastic Invasion and Metastasis. Am. J. Pathol.
168: 991-1003
[Abstract]
[Full Text]
-
Woodward, W. A., Chen, M. S., Behbod, F., Rosen, J. M.
(2005). On mammary stem cells. J. Cell Sci.
118: 3585-3594
[Abstract]
[Full Text]
-
Bertucci, F., Finetti, P., Rougemont, J., Charafe-Jauffret, E., Cervera, N., Tarpin, C., Nguyen, C., Xerri, L., Houlgatte, R., Jacquemier, J., Viens, P., Birnbaum, D.
(2005). Gene Expression Profiling Identifies Molecular Subtypes of Inflammatory Breast Cancer. Cancer Res.
65: 2170-2178
[Abstract]
[Full Text]
-
Teuliere, J., Faraldo, M. M., Deugnier, M.-A., Shtutman, M., Ben-Ze'ev, A., Thiery, J. P., Glukhova, M. A.
(2005). Targeted activation of {beta}-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia. Development
132: 267-277
[Abstract]
[Full Text]
-
Foulkes, W. D., Akslen, L. A.
(2004). RESPONSE: Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer. JNCI J Natl Cancer Inst
96: 714-714
[Full Text]
-
Konecny, G. E., Wilson, C. A., Slamon, D. J.
(2003). Is There a Role for Epidermal Growth Factor Receptor Inhibitors in Breast Cancer Prevention?. JNCI J Natl Cancer Inst
95: 1813-1815
[Full Text]